Navigation Links
Johnson & Johnson Presents Growth Strategies for Medical Devices & Diagnostics Segment
Date:1/22/2013

NEW YORK, Jan. 22, 2013 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will present its Medical Devices & Diagnostics (MD&D) business strategy for accelerating growth during its annual Business Review today. The presentations will focus on its market leading products, plans for global expansion and meaningful innovations in MD&D that position the company well for long-term growth in a dynamic market. Johnson & Johnson last highlighted its MD&D business in 2010.

"Our MD&D business is the largest medical technology business in the world with sales of $27.4 billion, which grew 8.7% operationally with the inclusion of Synthes," Alex Gorsky , Chairman and Chief Executive Officer, said. "We're building on our market leadership positions, having sustained or grown share in the majority of our key platforms, and hold number one or number two positions in over 80% of them today. We're also expanding our MD&D business in emerging markets, and with Synthes, generated strong double-digit growth there last year."

MD&D accounted for about 41% of Johnson & Johnson's total sales in 2012. Its businesses are global leaders with strong market positions across a broad range of areas, including orthopaedics, neurosurgery, general surgery, vision care, diabetes care, infection prevention, cardiovascular and aesthetics.

In the last two years, the company has invested approximately $3.5 billion in research and development for its MD&D segment, advancing its pipelines and developing new technologies and solutions across its businesses. It has also made decisions to shape its portfolio, including completing the approximately $20 billion acquisition of Synthes, Inc.--the largest acquisition in Johnson & Johnson history, while also continuing to take a disciplined approach to adapting its businesses to reflect the evolving needs of the marketplace."


'/>"/>
SOURCE Johnson & Johnson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alliqua Names David Johnson Executive Chairman of Aquamed Technologies and Member of Alliqua Board of Directors
2. Janssen and Johnson & Johnson to Provide Webcast Presentation of Immunology Pivotal Phase 3 Data Being Presented at the American College of Rheumatology Annual Meeting
3. Johnson & Johnson Postpones Medical Devices & Diagnostics Review
4. Johnson & Johnson to Host Medical Devices & Diagnostics Review
5. Johnson & Johnson Announces Plans to Establish Innovation Centers
6. Robert G. Savage, Former Worldwide Chairman, Johnson & Johnsons Pharmaceuticals Group, Joins Board of Nuovo Biologics, LLC
7. Johnson Health Tech Statement on Lance Armstrong
8. EFJohnson Announces Impact Partner Dealer Program
9. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
10. Johnson & Johnson Provides Notice Of Proposed Settlement Of Shareholder Derivative Actions, Final Settlement Hearing, And Right To Appear
11. GHX CEO Bruce Johnson Recognized as Ernst & Young Rocky Mountain Region Entrepreneur of the Year 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH) is celebrating a key ... Complete Knee System. , ... Zimmer first introduced the NexGen knee system, with its innovative ... million implantations of the NexGen knee have taken place worldwide. ... knee demonstrates the importance of design innovation and component quality for surgeons ...
(Date:3/27/2015)... -- CHINA AID, the 10 ... Medicine and Healthcare, second to none in ... at Shanghai New International Expo Center on 22-24 April. ... on Encouraging Private Capital to Participate in the Development ... by the Ministry of Civil Affairs of the ...
(Date:3/27/2015)... DALLAS , March 27, 2015 ... Market by Product (Diagnostic Catheter (Conventional, Advanced, Ultrasound), Ablation ... ICE, X-ray)) & Indication (AF, VT, WPW) - Global ... Market is expected to reach around ~$4.73 Billion by ... forecast period 2014 to 2019. Browse ...
Breaking Medicine Technology:Zimmer Celebrates Key Milestones For NexGen Complete Knee System 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 2CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 3CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 4CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 5CHINA AID, the 10th China International Exhibition of Senior Care, Rehabilitation Medicine and Healthcare to be held in April 6Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4
... (NASDAQ: OPTR ) today announced that the Company ... JMP Securities Tenth Annual Research Conference on Tuesday, May 10, ... San Francisco. Bank of America Merrill Lynch 2011 Health ... Pacific Time at Encore at Wynn Las Vegas. UBS ...
... EAST BRUNSWICK, N.J., April 29, 2011 Savient ... announced that it has named Richard Crowley Executive ... 2011.  Mr. Crowley brings extensive pharmaceutical industry knowledge ... of Savient,s manufacturing, regulatory, quality, project management and ...
Cached Medicine Technology:Optimer Pharmaceuticals to Present at May 2011 Investor Conferences 2Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations 2Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations 3Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations 4Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations 5
(Date:3/28/2015)... 2015 "Necrorun" was featured on NewsWatch ... look at the latest and coolest applications on the ... host of NewsWatch and technology expert, conducted the app ... entertaining endless runner game with knights, nature, and peasants. ... in 2009, according to Eurogamer. The popularity of these ...
(Date:3/28/2015)... NY (PRWEB) March 28, 2015 Emergency ... offers urgent care in Manhattan, recently commemorated its three-year ... facility in Manhattan. In addition to 24-hour urgent care, ... facilities. , At this time, Emergency Medical Care’s ... abdominal pain, asthma, chest pain, eye injuries, ear infections, ...
(Date:3/28/2015)... 28, 2015 One in three young ... research presented today at the American Orthopaedic Society for ... examined the long term success of surgery for patients ... survey data from 242 patients who underwent ACL reconstruction ... Roe, MBBS, FRACS, from North Sydney Orthopaedic and Sports ...
(Date:3/28/2015)... San Francisco, California (PRWEB) March 28, 2015 ... search for original 1960's Who psychedelic concert posters. The Who ... Flushing, New York on August 2, 1968. According to Hawley, ... 1969 playing many concert halls and college campuses. Perhaps the ... their performance with Jim Morrison and the Doors on August ...
(Date:3/28/2015)... California (PRWEB) March 28, 2015 Designers ... a new overlay entitled Scratches 5K from Pixel Film ... scratch effects to any media inside Final Cut Pro ... “StoryBoard Corporate saves time and is an effective tool ... using FCPX Overlay Scratches 5K's intuitive grunge overlays. Simply ...
Breaking Medicine News(10 mins):Health News:A Grim Endless Runner Game Was Featured on NewsWatch Television on January 30, 2015 2Health News:Emergency Medical Care Celebrates Three Years of 24/7 Walk-In Urgent Care Services 2Health News:Young Athletes at Greater Risk for Re-Injury after ACL Surgery 2Health News:Avid Collector from Vintage Rock Posters, Inc. Announces His Search For Original 1960's Who Psychedelic Concert Posters. 2Health News:Pixel Film Studios Unveiled Scratches 5k for Final Cut Pro X Editors 2
... in mice provides clues to variations in disease progression , ... have been linked to improvements in the body,s ability to ... more effective treatments, a U.S. scientist reports. , "Most MS ... some people get MS and others do not," study author ...
... Best known as the oxygen-carrying component of hemoglobin, ... a role in chemical detoxification and energy metabolism within ... good reason: Too little heme prevents cell growth and ... Researchers at the University of Pennsylvania School of Medicine ...
... , Minnesota,s Linda Hamilton Selected ... , , SILVER SPRING, Md., Sept. 11 ... AFL-CIO will honor the work of UAN,s Linda Hamilton, RN, and ... voices heard. , , Building on a lifetime ...
... , , DETROIT, Sept. 11 ... announced an interim policy to automatically cover the cost of administration ... customer groups and individual coverage during the 2009-2010 flu season--unless a ... , The Blues also announced that it will ...
... MIAMI, Sept. 11 At a press conference held in Coral ... details of the organization,s alliance with Navarro Discount Pharmacies. Centro Mater ... children from six weeks to 12 years of age. The ... Miami-Dade County - two in Hialeah, two in Little Havana, and ...
... , GREENSBORO, N.C., Sept. 11 Merz ... that the U.S. Food and Drug Administration (FDA) has ... Belotero(R) Balance. , , Belotero(R) ... filler that utilizes a cohesive polydensified matrix (CPM(TM)) technology. ...
Cached Medicine News:Health News:Inner workings of molecular thermostat point to pathways to fight diabetes, obesity 2Health News:Inner workings of molecular thermostat point to pathways to fight diabetes, obesity 3Health News:UAN Nurse Among Political Activists To Be Honored by AFL-CIO 2Health News:Blue Cross Blue Shield of Michigan and Blue Care Network Announce Interim Policy to Cover H1N1 Vaccine Administration for Fully-Insured Groups During 2009-2010 Flu Season 2Health News:Alliance Between Centro Mater and Navarro Discount Pharmacies 2Health News:Merz Pharmaceuticals' Belotero(R) Balance PMA Filing Formally Accepted for Review by the FDA 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: